Controversies in drug allergy: Testing for delayed reactions

Elizabeth J. Phillips, Paul L Bigliardi, Andreas J. Bircher, Ana Broyles, Yoon Seok Chang, Wen Hung Chung, Rannakoe Lehloenya, Maja Mockenhaupt, Jonny Peter, Munir Pirmohamed, Jean Claude Roujeau, Neil H. Shear, Luciana Kase Tanno, Jason Trubiano, Rocco Valluzzi, Annick Barbaud

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Controversies exist with regard to in vivo approaches to delayed immunologically mediated adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome/toxic epidermal necrolysis, and fixed drug eruptions. In particular, widespread differences exist between regions and practice on the availability and use of intradermal and patch testing, the standard drug concentrations used, the use of additional drugs in intradermal and patch testing to help determine cross-reactivity, the timing of testing in relation to the occurrence of the adverse drug reaction, the use of testing in specific phenotypes, and the use of oral challenge in conjunction with delayed intradermal and patch testing to ascertain drug tolerance. It was noted that there have been advances in the science of delayed T cell–mediated reactions that have shed light on immunopathogenesis and provided a mechanism of preprescription screening in the case of HLA-B*57:01 and abacavir hypersensitivity and HLA-B*15:02 and carbamazepine Stevens-Johnson syndrome/toxic epidermal necrolysis in Southeast Asian subjects. Future directions should include the collaboration of large international networks to develop and standardize in vivo diagnostic approaches, such as skin testing and patch testing, combined with ex vivo and in vitro laboratory approaches.

Original languageEnglish (US)
Pages (from-to)66-73
Number of pages8
JournalJournal of Allergy and Clinical Immunology
Volume143
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Drug Eruptions
Drug Hypersensitivity
Stevens-Johnson Syndrome
Drug-Related Side Effects and Adverse Reactions
Acute Generalized Exanthematous Pustulosis
Drug Hypersensitivity Syndrome
Drug Tolerance
HLA-B Antigens
Carbamazepine
Pharmaceutical Preparations
Hypersensitivity
Phenotype
Skin
abacavir
HLA-B57 antigen
Direction compound
In Vitro Techniques

Keywords

  • Delayed
  • HLA
  • Stevens-Johnson syndrome/toxic epidermal necrolysis
  • acute generalized exanthematous pustulosis
  • drug reaction with eosinophilia and systemic symptoms
  • fixed drug eruption
  • intradermal
  • oral challenge
  • patch
  • prick

Cite this

Phillips, E. J., Bigliardi, P. L., Bircher, A. J., Broyles, A., Chang, Y. S., Chung, W. H., ... Barbaud, A. (2019). Controversies in drug allergy: Testing for delayed reactions. Journal of Allergy and Clinical Immunology, 143(1), 66-73. https://doi.org/10.1016/j.jaci.2018.10.030

Controversies in drug allergy : Testing for delayed reactions. / Phillips, Elizabeth J.; Bigliardi, Paul L; Bircher, Andreas J.; Broyles, Ana; Chang, Yoon Seok; Chung, Wen Hung; Lehloenya, Rannakoe; Mockenhaupt, Maja; Peter, Jonny; Pirmohamed, Munir; Roujeau, Jean Claude; Shear, Neil H.; Tanno, Luciana Kase; Trubiano, Jason; Valluzzi, Rocco; Barbaud, Annick.

In: Journal of Allergy and Clinical Immunology, Vol. 143, No. 1, 01.01.2019, p. 66-73.

Research output: Contribution to journalReview article

Phillips, EJ, Bigliardi, PL, Bircher, AJ, Broyles, A, Chang, YS, Chung, WH, Lehloenya, R, Mockenhaupt, M, Peter, J, Pirmohamed, M, Roujeau, JC, Shear, NH, Tanno, LK, Trubiano, J, Valluzzi, R & Barbaud, A 2019, 'Controversies in drug allergy: Testing for delayed reactions', Journal of Allergy and Clinical Immunology, vol. 143, no. 1, pp. 66-73. https://doi.org/10.1016/j.jaci.2018.10.030
Phillips, Elizabeth J. ; Bigliardi, Paul L ; Bircher, Andreas J. ; Broyles, Ana ; Chang, Yoon Seok ; Chung, Wen Hung ; Lehloenya, Rannakoe ; Mockenhaupt, Maja ; Peter, Jonny ; Pirmohamed, Munir ; Roujeau, Jean Claude ; Shear, Neil H. ; Tanno, Luciana Kase ; Trubiano, Jason ; Valluzzi, Rocco ; Barbaud, Annick. / Controversies in drug allergy : Testing for delayed reactions. In: Journal of Allergy and Clinical Immunology. 2019 ; Vol. 143, No. 1. pp. 66-73.
@article{0d33599c43b2454cb9a0ad0747e9ea62,
title = "Controversies in drug allergy: Testing for delayed reactions",
abstract = "Controversies exist with regard to in vivo approaches to delayed immunologically mediated adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome/toxic epidermal necrolysis, and fixed drug eruptions. In particular, widespread differences exist between regions and practice on the availability and use of intradermal and patch testing, the standard drug concentrations used, the use of additional drugs in intradermal and patch testing to help determine cross-reactivity, the timing of testing in relation to the occurrence of the adverse drug reaction, the use of testing in specific phenotypes, and the use of oral challenge in conjunction with delayed intradermal and patch testing to ascertain drug tolerance. It was noted that there have been advances in the science of delayed T cell–mediated reactions that have shed light on immunopathogenesis and provided a mechanism of preprescription screening in the case of HLA-B*57:01 and abacavir hypersensitivity and HLA-B*15:02 and carbamazepine Stevens-Johnson syndrome/toxic epidermal necrolysis in Southeast Asian subjects. Future directions should include the collaboration of large international networks to develop and standardize in vivo diagnostic approaches, such as skin testing and patch testing, combined with ex vivo and in vitro laboratory approaches.",
keywords = "Delayed, HLA, Stevens-Johnson syndrome/toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fixed drug eruption, intradermal, oral challenge, patch, prick",
author = "Phillips, {Elizabeth J.} and Bigliardi, {Paul L} and Bircher, {Andreas J.} and Ana Broyles and Chang, {Yoon Seok} and Chung, {Wen Hung} and Rannakoe Lehloenya and Maja Mockenhaupt and Jonny Peter and Munir Pirmohamed and Roujeau, {Jean Claude} and Shear, {Neil H.} and Tanno, {Luciana Kase} and Jason Trubiano and Rocco Valluzzi and Annick Barbaud",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jaci.2018.10.030",
language = "English (US)",
volume = "143",
pages = "66--73",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Controversies in drug allergy

T2 - Testing for delayed reactions

AU - Phillips, Elizabeth J.

AU - Bigliardi, Paul L

AU - Bircher, Andreas J.

AU - Broyles, Ana

AU - Chang, Yoon Seok

AU - Chung, Wen Hung

AU - Lehloenya, Rannakoe

AU - Mockenhaupt, Maja

AU - Peter, Jonny

AU - Pirmohamed, Munir

AU - Roujeau, Jean Claude

AU - Shear, Neil H.

AU - Tanno, Luciana Kase

AU - Trubiano, Jason

AU - Valluzzi, Rocco

AU - Barbaud, Annick

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Controversies exist with regard to in vivo approaches to delayed immunologically mediated adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome/toxic epidermal necrolysis, and fixed drug eruptions. In particular, widespread differences exist between regions and practice on the availability and use of intradermal and patch testing, the standard drug concentrations used, the use of additional drugs in intradermal and patch testing to help determine cross-reactivity, the timing of testing in relation to the occurrence of the adverse drug reaction, the use of testing in specific phenotypes, and the use of oral challenge in conjunction with delayed intradermal and patch testing to ascertain drug tolerance. It was noted that there have been advances in the science of delayed T cell–mediated reactions that have shed light on immunopathogenesis and provided a mechanism of preprescription screening in the case of HLA-B*57:01 and abacavir hypersensitivity and HLA-B*15:02 and carbamazepine Stevens-Johnson syndrome/toxic epidermal necrolysis in Southeast Asian subjects. Future directions should include the collaboration of large international networks to develop and standardize in vivo diagnostic approaches, such as skin testing and patch testing, combined with ex vivo and in vitro laboratory approaches.

AB - Controversies exist with regard to in vivo approaches to delayed immunologically mediated adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome/toxic epidermal necrolysis, and fixed drug eruptions. In particular, widespread differences exist between regions and practice on the availability and use of intradermal and patch testing, the standard drug concentrations used, the use of additional drugs in intradermal and patch testing to help determine cross-reactivity, the timing of testing in relation to the occurrence of the adverse drug reaction, the use of testing in specific phenotypes, and the use of oral challenge in conjunction with delayed intradermal and patch testing to ascertain drug tolerance. It was noted that there have been advances in the science of delayed T cell–mediated reactions that have shed light on immunopathogenesis and provided a mechanism of preprescription screening in the case of HLA-B*57:01 and abacavir hypersensitivity and HLA-B*15:02 and carbamazepine Stevens-Johnson syndrome/toxic epidermal necrolysis in Southeast Asian subjects. Future directions should include the collaboration of large international networks to develop and standardize in vivo diagnostic approaches, such as skin testing and patch testing, combined with ex vivo and in vitro laboratory approaches.

KW - Delayed

KW - HLA

KW - Stevens-Johnson syndrome/toxic epidermal necrolysis

KW - acute generalized exanthematous pustulosis

KW - drug reaction with eosinophilia and systemic symptoms

KW - fixed drug eruption

KW - intradermal

KW - oral challenge

KW - patch

KW - prick

UR - http://www.scopus.com/inward/record.url?scp=85058976506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058976506&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2018.10.030

DO - 10.1016/j.jaci.2018.10.030

M3 - Review article

C2 - 30573342

AN - SCOPUS:85058976506

VL - 143

SP - 66

EP - 73

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -